Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $245.38 million. The enterprise value is $159.72 million.
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 17.77 million shares outstanding. The number of shares has increased by 135.33% in one year.
| Current Share Class | 17.77M |
| Shares Outstanding | 17.77M |
| Shares Change (YoY) | +135.33% |
| Shares Change (QoQ) | +152.10% |
| Owned by Insiders (%) | 2.05% |
| Owned by Institutions (%) | 68.76% |
| Float | 11.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.92 |
| Forward PS | 1.87 |
| PB Ratio | 1.63 |
| P/TBV Ratio | 1.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.47, with a Debt / Equity ratio of 0.64.
| Current Ratio | 7.47 |
| Quick Ratio | 5.93 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.03 |
Financial Efficiency
Return on equity (ROE) is -87.65% and return on invested capital (ROIC) is -18.17%.
| Return on Equity (ROE) | -87.65% |
| Return on Assets (ROA) | -15.79% |
| Return on Invested Capital (ROIC) | -18.17% |
| Return on Capital Employed (ROCE) | -30.25% |
| Revenue Per Employee | $337,017 |
| Profits Per Employee | -$276,559 |
| Employee Count | 354 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.33 |
Taxes
In the past 12 months, Outset Medical has paid $397,000 in taxes.
| Income Tax | 397,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +87.98% in the last 52 weeks. The beta is 2.13, so Outset Medical's price volatility has been higher than the market average.
| Beta (5Y) | 2.13 |
| 52-Week Price Change | +87.98% |
| 50-Day Moving Average | 16.15 |
| 200-Day Moving Average | 14.62 |
| Relative Strength Index (RSI) | 44.53 |
| Average Volume (20 Days) | 181,214 |
Short Selling Information
The latest short interest is 2.19 million, so 12.31% of the outstanding shares have been sold short.
| Short Interest | 2.19M |
| Short Previous Month | 2.16M |
| Short % of Shares Out | 12.31% |
| Short % of Float | 19.39% |
| Short Ratio (days to cover) | 6.15 |
Income Statement
In the last 12 months, Outset Medical had revenue of $119.30 million and -$97.90 million in losses. Loss per share was -$12.30.
| Revenue | 119.30M |
| Gross Profit | 43.87M |
| Operating Income | -76.19M |
| Pretax Income | -158.67M |
| Net Income | -97.90M |
| EBITDA | -70.95M |
| EBIT | -76.19M |
| Loss Per Share | -$12.30 |
Full Income StatementBalance Sheet
The company has $184.09 million in cash and $98.43 million in debt, giving a net cash position of $85.66 million or $4.82 per share.
| Cash & Cash Equivalents | 184.09M |
| Total Debt | 98.43M |
| Net Cash | 85.66M |
| Net Cash Per Share | $4.82 |
| Equity (Book Value) | 154.78M |
| Book Value Per Share | 8.50 |
| Working Capital | 238.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$67.54 million and capital expenditures -$853,000, giving a free cash flow of -$68.40 million.
| Operating Cash Flow | -67.54M |
| Capital Expenditures | -853,000 |
| Free Cash Flow | -68.40M |
| FCF Per Share | -$3.85 |
Full Cash Flow StatementMargins
Gross margin is 36.77%, with operating and profit margins of -63.87% and -82.06%.
| Gross Margin | 36.77% |
| Operating Margin | -63.87% |
| Pretax Margin | -81.73% |
| Profit Margin | -82.06% |
| EBITDA Margin | -59.47% |
| EBIT Margin | -63.87% |
| FCF Margin | n/a |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -135.33% |
| Shareholder Yield | -135.33% |
| Earnings Yield | -39.90% |
| FCF Yield | -27.87% |
Analyst Forecast
The average price target for Outset Medical is $22.00, which is 59.54% higher than the current price. The consensus rating is "Hold".
| Price Target | $22.00 |
| Price Target Difference | 59.54% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 13.73% |
| EPS Growth Forecast (5Y) | -66.13% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 20, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Mar 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
Outset Medical has an Altman Z-Score of -4.4 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.4 |
| Piotroski F-Score | 5 |
